利用机器学习衍生的生物计算方法增强抗生素发现的综合指南
A Comprehensive Guide to Enhancing Antibiotic Discovery Using Machine Learning Derived Bio-computation
AI总结:
本文综述了AI和ML工具在加速药物发现中的应用,并讨论了数据稀缺、伦理问题及对抗生素发现和应对抗菌素耐药性的促进作用。
摘要:
传统药物发现是一个漫长、昂贵且复杂的过程。人工智能(AI)和机器学习(ML)的进展正开始改变这一局面。在此,我们全面概述了可用于简化和加速药物发现过程的不同AI和ML工具。通过使用数据集训练ML算法,可以相对快速且高效地发现药物或类药物化合物。此外,我们探讨了基于AI的药物发现与开发中的局限性,包括用于训练AI模型的高质量数据稀缺以及伦理考量。AI对制药行业日益增长的影响也得到了强调。最后,我们讨论了AI和ML如何加速新抗生素的发现,以应对全球抗菌素耐药性(AMR)问题。
英文摘要:
Traditional drug discovery is a long, expensive, and complex process. Advances in Artificial Intelligence (AI) and Machine Learning (ML) are beginning to change this narrative. Here, we provide a comprehensive overview of different AI and ML tools that can be used to streamline and accelerate the drug discovery process. By using data sets to train ML algorithms, it is possible to discover drugs or drug-like compounds relatively quickly, and efficiently. Additionally, we address limitations in AI-based drug discovery and development, including the scarcity of high-quality data to train AI models and ethical considerations. The growing impact of AI on the pharmaceutical industry is also highlighted. Finally, we discuss how AI and ML can expedite the discovery of new antibiotics to combat the problem of worldwide antimicrobial resistance (AMR).
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。